Blephasteam® is an eyelid warming device designed to be an easy-to-use and standardized treatment for Meibomian Gland Disease (MGD). In the present study, 73 patients were treated for 21 days with twice daily Blephasteam® sessions. There were... improvements in a number of efficacy variables including subjective ocular symptoms and clinical signs and symptoms of MGD and dry eye, though tear film breakup time and tear osmolarity were not improved. Global efficacy was assessed as satisfactory or very satisfactory in 83.8% of cases. Patient-reported subjective ocular symptoms declined during the study, and a majority of patients rated the efficacy of Blephasteam® as satisfactory or very satisfactory. Most patients found the device comfortable and were able to continue with normal activities (reading, watching TV, using a computer) during the Blephasteam® session. No safety or tolerability issues were identified.
Blephasteam appears to be available in Europe and can be ordered from it's website.